• Alexandru Burlacu, Radu Crisan-Dabija, Iolanda Valentina Popa, and Adrian Covic.
• Department of Interventional Cardiology-Cardiovascular Diseases Institute, 700503 Iasi, Romania.
• Medicina (Kaunas). 2020 Dec 18; 56 (12).

AbstractCoinfection with both SARS-CoV-2 and influenza viruses seems to be a real and severe problem. However, coinfection is far from a simple matter, and cannot be considered having more unfavorable outcomes as a direct consequence. In reality, the aftermath is powerfully nuanced by the presence of risk factors and specific molecular mechanisms. Our objective was to raise awareness around the unpredictable association between COVID-19 pandemics and the upcoming flu season, and make arguments about the need to develop new routine testing protocols for both viruses, at least during the period with an expected high incidence. Our reasoning is built around the various impacts that the whole range of risk groups, common immunological mechanisms, and complex interactions, such as influenza vaccination, will have on patients' prognosis. We show that the more flawed clinical course is due to managing only one of the infections (and, subsequently, neglecting the other condition).

23 keywords...

hide…